Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like I said thin ice. It is all well and good as long as you are skating on top. But when you go under, there is pain and remorse.
IF I didn't already own shares there is no way I would be buying this.
Talk about thin ice. Yeah there are other stocks with much less risk. Hard to imagine that anyone else would take that chance. As you mentioned there are liabilities here. I also think there may be unknowns. There may be things that have been in development that we may not be aware of. And when you see a whale buying up shares, I can only imagine that they know something or how in the world would they be willing to invest hundreds of thousands in a shell? What ever happened with the pharmacy kiosk territory, anyone know? Or what about the CBD inhaler supposedly a patent?
What would you say the odds are of this ever going back to .0025?
That is an interesting theory and we are on the same page but the idea that short manipulation brought this pps down, I am not seeing it. Another thing is when you look at the value of a company and hence the share price that is based on things like revenue, products, contracts, holdings etc. As Red Sox and Hatter have so eloquently articulated, Dewmar is deficient to the point that anything above .0001 is undeserved kindness, plus we have a Ceo who has not given us a pr since 03/17 and is on his way to the jail house. So on what basis would you say Dewm is worth anything? If you can think of anything beyond the fact that someone has been buying cheapies please let us know. My only hope is a Reverse Merger or Moran handing the company over to another CEO. It does not seem, that Moran has been responsible as a Ceo on so many levels and I see nothing to show for it.
Seems that it has been established from recent posts and from looking at a history of other Corporate Ceos who have committed crimes and been found guilty, that it did not always affect the corporation. So going back and forth on, is he going to jail or isn't he going to jail becomes rather repetitive and mundane. What is salient in this case regarding the corporation will be somewhat of an unknown. Unless you have a crystal ball and know how to use it, I would suggest being patient and see what develops.
Thinking we will know something today about the future of our pps. Is the support still there from our unknown buyer? Or will they throw in the towel? Lets see how this unfolds
This has really become very interesting. It is like a mystery game. We have suspects, a detective, a news reporter, a Doctor, a jury and judge. I love the suspense (am I the only one?) I mean you gotta love this, a real life crime drama with clues but no smoking gun or is there? Characters with pseudonyms, a plot, a conspiracy. And then you have winners and losers. So far I would say anyone selling at .0005 or there about have been set out of the game for now. And yet they stay because there is always this nagging shoulder angel or demon that wants to remind us whether we made the right move or not.
And as of now there are the facts of the case. Which have a mountain of evidence that there is no hope for the company or for longs holding the stock. Conversely we have stubborn (balls of steel) players that are riding the storm out purely on the basis of numbers and the mathematics of ebb and flow of shares traded.
And nobody really knows who will lose and who will win. Pick a card, turn the nob, spin the wheel, roll the dice. Only time will tell. What will tomorrow bring, a total sell off or continued volume bringing us back to the mid .002s? This isn't play money though and that makes it even more interesting. This is real, this is not a game. Are you in? Are you out? Are you a spectator? Me? I'm in.
Well Moran knew that there would be a big sell off and had time to prepare a third party or whomever. I keep thinking to those FB posts supposedly from him where he said Tell your friends to buy up as many cheapies as they can. Something like that. This was some of the last posts on the Dewm FB. So he either wanted everyone to get burned or he was intimating that there would be a recovery of price. Didn't he also imply that his charges would not affect Dewm? Pretty sure he did.
Perfect play here. Do the Math
"All of my friends know the low rider
the low rider is a little higher
Low rider drives a little slower
Low rider is a real goer."
Take a little trip take a little trip
Take a little trip take a little trip with mee
When I think that nearly a billion shares have been taken out of the hands of investors who had been holding for, in some cases years, Where did those shares go? Who got them? Is it possible that Moran did? OR a company doing a RM? With that many shares being taken out of the market, I would say expect anything. Strange Brew. Could it be that the billion shares would be a means to grab some fast cash, now that they are in Moran's hands a big PR and the money would all go to him? I really am not an expert but this does seem orchestrated.
This is great news. Time to buy more.
“This was the final piece to the puzzle,” said Vanessa Luna, MTrac’s CEO. “In the last few months our sales and marketing team have worked diligently to successfully execute agreements and approve over 60% of the San Diego cannabis market who will implement this system over the next 30 days.
Good Morning Longs. $DEWM... Lets see what unfolds for those with "balls of steel."
Seems like I recall Dewmar handling the overseas distribution for Rocky Mt. High.
Good vibes. I am astounded at this performance. Tell me somebody doesn't know something at this point. Was it a billion shares that sold since last Monday?
For a time I lived not far from the Scion location. And it was always timber industry. In fact I worked for Weyerhauser planting trees in the Cascades. Hemp will be a better option for paper products etc. And if I am not mistaken when hemp was made illegal it had much to do with paper products and who owned large plots of land for growing timber.
Thanks for the post.
Nice advertisement, right. I tried posting the photo but it wouldn't show on this page. Can you get a copy of the photo and post it here?
Imagine my surprise seeing Swiss Ice Tea on Marketwatch article today. Not what I was expecting at all.
This is an article that is curently on Marketwatch. The photo at the top of the article has two cans of Dewmar's Swiss Ice Tea. Suck it up HP.
The article is entitled "Cannabis stocks rally on continued excitement about CBD-infused drinks." Look for it under column "Inside Marketwatch."
Cannabis stocks were mostly sharply higher Monday, with India Globalization Capital Inc. a standout, adding another 18% on excitement about its plans for the CBD-infused-energy-drink market.
Maryland-based India Globalization’s stock IGC, +39.58% gained 27% on Friday after it revealed the plans, pulling the stocks of other companies already involved with the cannabinoid higher with it.
The overall cannabis sector has been on a tear for the past few months as investors position themselves for the start of full legalization of cannabis in Canada on Oct. 17, the first developed country to take that step.
Canadian companies have been gearing up for the move — and posting outsize stock gains — and newswires have been flush with announcements of deals, alliances, production and supply agreements and emerging companies, keen to take advantage of what is expected to be a multibillion-dollar market.
But in all the euphoria, investors, and retail investors in particular, need to do their due diligence to be sure the companies they are investing in have legitimate businesses. The Securities and Exchange Commission has issued an investor alert warning that promises of guaranteed high returns on investments are a red flag for fraud.
“Fraudsters may manipulate stock prices (for example, causing them to rise or fall dramatically) by spreading false and misleading information about a company,” it reads. “Microcap stocks, some of which are penny stocks and/or nanocap stocks, may be more susceptible to market manipulation than stocks of larger companies.”
Investors have become increasingly keen on CBD, a nonpsychoactive component of marijuana, that is being used in drinks and beverages as a health boost. The beer industry has proved especially interested, given the growing evidence that people are using cannabis to replace alcohol, while big soda companies are turning to CBD to build out their wellness offerings at a time when consumers are avoiding sugar.
See now: Why millennials prefer cannabis to booze: ‘Zero enjoyment out of drinking’ (and it’s cheaper)
The Drug Enforcement Administration said last week that it now places FDA-approved drugs with CBD in “Schedule V,” defined as having the lowest potential for abuse, such as over-the-counter treatments for diarrhea and cough suppressants. Cannabis itself remains a Schedule I drug, which places it alongside heroin and LSD as substances that are fully banned at the federal level. That classification has hampered the development of the U.S. sector as companies are unable to have bank accounts that are federally insured, handing Canada a valuable first-mover advantage.
Read now: GW Pharma stock jumps to record after DEA stance on its CBD drug, cannabis sector lags
The Toronto-based Green Organic Dutchman Holdings Inc. said Monday it has entered a C$75 million deal with an underwriting syndicate led by Canaccord. Proceeds of the deal are to be used to finance international expansion and for the catchall general corporate purposes.
Shares of Canada’s Tilray Inc. TLRY, +4.22% surged another 13% Monday, bringing its one-month gains to 149%. Other Canadian stocks were also higher, with Aurora Cannabis Inc. ACBFF, +1.07% ACB, +0.40% up 3%, Canopy Growth Corp. CGC, +0.12% up 3%, Valens GroWorks Corp. MYMSF, +1.47% up 3.7%, Cronos Group Inc. CRON, +0.62% up 5.8% and iAnthus Capital Holdings Inc. ITHUF, +0.89% up 5%.
Don’t miss: Exclusive: Largest Canadian province to unveil retail cannabis rules this week
Also: The Berkshire Hathaway of cannabis companies benefits from other pot stocks’ rise
Related: Did you miss the wild ride in Tilray stock and want to invest in cannabis? Beware of rogue players
Aleafia Health Inc. stock’s ALEF, -1.29% slid 1.9%, as investors took profits on last week’s 27% gain. The company said it is planning to expand into retail operations and entered a supply agreement with CannTrust Holdings Inc. TRST, -2.05% , which was also down about 2%.
Among U.S. stocks, New Age Beverages Corp. NBEV, +11.28% , another CBD drinks player, soared another 38%, adding to gains that have totaled 395% in the past month. That company is planning to debut a line of CBD-infused drinks at the North American Convenience Store show in Las Vegas on Oct. 8.
Rival Level Brands Inc. LEVB, +21.20% , which is offering CBD drinks under the Kathy Ireland Health and Wellness brand, rose another 38%.
Cannabis Sativa Inc. CBDS, +29.20% was up 10% and GrowGeneration Corp. GRWG, +2.79% was down 2%. GW Pharmaceuticals PLC’s stock GWPH, -3.17% which makes the only FDA-approved, CBD-derived drug, Epidiolex for the treatment of pediatric epilepsy, was down about 2%.
The ETFMG Alternative Harvest ETF MJ, +1.62% was up 3% and the Horizons Marijuana Life Sciences ETF HMMJ, +0.90% was up 2%. The S&P 500 SPX, +0.36% was up 0.7%, and the Dow Jones Industrial Average DJIA, +0.73% was up 1%.
Yes J V. We are hoping to be back at.002 sometime soon. News of Reverse Merger may just put us back to pre Moran Debacle news.
So why would anyone buy 750K in a company that is heading for the gates of Gehenna?
Thanks for the link. Interesting to see that a RM can happen within 30 days.
That is amazing.
Good Morning Longs. There is a theory that I have been kicking around and it came from my research regarding another company that I recently became familiar with namely Global Payout (gohe) and while I am not a big trader I have seen a few things as Farmer says. It seems there was a three way reverse merger involving Mtrack, and Mcoa. I think I have that right. And my theory is this, is it possible that there is a reverse merger in process with DEWM? Is it also possible that the company that is merging with Dewmar is also buying up every share that gets sold on panic? How may shares now is it, around 6 or 7 hundred million?
My understanding of a Reverse Merger is that there is a company that is making money but does not want to go through the laborious project and cost of going public and so they will merge with a company that is. In that event Dewm having products would not be so relevant but rather the open market opportunity. Wouldn't that be a pip?
Would August 19 and today be considered a double bottom?
Good Morning fellow longs. Somehow the pps is being propped up at .0005. Anyone know how this is possible?
If it is Dewm, no thanks I have enough. lol
Let me tell you if no one from Cardinal or McKesson went to jail, how does it happen that Moran gets locked up? Not going to happen. Too bad so sad.
Have you ever listened to the words of the song, Dirty Laundry, "I make my living off the evening news, just give me something, something I can use, Can we film the operation is the head dead yet? The boys in the news room have got a running bet, Dirty little secrets, dirty little lies, we got our dirty little fingers in everybody's pie, we love to cut you down to size we love dirty laundry. Kick em when they're up, kick em when they're down."
My point is you do this for a living and what you do for a living is to play this as far as you can, to make it a huge story and that means perks for you. Sorry we are not on the same page. I invested my hard earned money in this company and without knowledge of impropriety. You have cast an unfavorable shadow on investors of this company and made disparaging comments to that affect.
You are playing this to see how far you can drag Moran down and everyone here who is holding stock in this company. But it is really not about righting wrongs done to Vets imo. It is about promotions, paychecks and making a big name in the media. good luck patriot.
Good morning Dewm longs. As Steve Martin once said in the film "mixed nuts," "There is hope in every pot hole." Speaking about the letters. And there is hope here to get back money imo that has been invested, by being patient and looking for a bounce. As I have said in recent posts, the big players who rip off millions imo. and are responsible for hundreds of deaths and thousands of overdoses on narcotics, go unscathed. ie. McKesson and Cardinal Health. Still operating and making huge money. Because Moran isn't as big as them and for far less crimes, he faces the lynch mob? And there are bitter people who want to see that imo. A reporter who seems to have a bitter, personal vendetta. A detective (self proclaimed, from a film about eating people's remains,) who has very seldom if ever, said anything positive about this company. And who missed entirely the fact that Moran was not only being investigated but on trial for some months all the way to a plea deal. And even some who have stood firmly on the side of Dewm for many years have turned to a thumbs down mentality.
Lets look to the positive, 1. If the entire trial went on unnoticed by the best of this board, it is likely that other things are presently unknown. So there is guessing and sometimes that guess work is presented as facts.
2. Clues are present. Don't be swayed by the mob.
A. Someone has vigorously been grabbing up shares.
B. Moran seemed to indicate, post plea, to grab cheapies. Perhaps a word to the patient and unwavering supporters. Knowing that panic sellers would make up the greater number.
C. The company has yet to be shut down and the SEC has yet to shut down the market on trading Dewm.
In conclusion and In my case I am not ready to surrender. As Dido said " I will go down with this ship. I won't put my hands up and surrender, there will be no white flag above my door."
If you are going to scream at me perhaps make your letters in caps. That would be more effective.
Lets talk about Evil and abuse regarding companies that are thriving in the medical industry Cardinal Health and Mckesson
The drug industry’s triumph over the DEA
Amid a targeted lobbying effort, Congress weakened the DEA’s ability to go after drug distributors, even as opioid-related deaths continue to rise, a Washington Post and ‘60 Minutes’ investigation finds.
By Scott Higham and Lenny Bernstein
Oct. 15, 2017
Share on Facebook
In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent weapon against large drug companies suspected of spilling prescription narcotics onto the nation’s streets.
By then, the opioid war had claimed 200,000 lives, more than three times the number of U.S. military deaths in the Vietnam War. Overdose deaths continue to rise. There is no end in sight.
A handful of members of Congress, allied with the nation’s major drug distributors, prevailed upon the DEA and the Justice Department to agree to a more industry-friendly law, undermining efforts to stanch the flow of pain pills, according to an investigation by The Washington Post and “60 Minutes.” The DEA had opposed the effort for years.
The law was the crowning achievement of a multifaceted campaign by the drug industry to weaken aggressive DEA enforcement efforts against drug distribution companies that were supplying corrupt doctors and pharmacists who peddled narcotics to the black market. The industry worked behind the scenes with lobbyists and key members of Congress, pouring more than a million dollars into their election campaigns.
The chief advocate of the law that hobbled the DEA was Rep. Tom Marino,
a Pennsylvania Republican who is now President Trump’s nominee to become the nation’s next drug czar. Marino spent years trying to move the law through Congress. It passed after Sen. Orrin G. Hatch
(R-Utah) negotiated a final version with the DEA.
8:45
This Pennsylvania district was devastated by opioids. Their Congressman became an ally of the drug industry. (Video: Alice Li/Photo: Michael S. Williamson/The Washington Post)
For years, some drug distributors were fined for repeatedly ignoring warnings from the DEA to shut down suspicious sales of hundreds of millions of pills, while they racked up billions of dollars in sales.
The new law makes it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies, according to internal agency and Justice Department documents and an independent assessment by the DEA’s chief administrative law judge in a soon-to-be-published law review article. That powerful tool had allowed the agency to immediately prevent drugs from reaching the street.
Political action committees representing the industry contributed at least $1.5 million to the 23 lawmakers who sponsored or co-sponsored four versions of the bill, including nearly $100,000 to Marino and $177,000 to Hatch. Overall, the drug industry spent $102 million lobbying Congress on the bill and other legislation between 2014 and 2016, according to lobbying reports.
[TUESDAY UPDATE: Trump announces drug czar Marino will withdraw]
“The drug industry, the manufacturers, wholesalers, distributors and chain drugstores, have an influence over Congress that has never been seen before,” said Joseph T. Rannazzisi,
who ran the DEA’s division responsible for regulating the drug industry and led a decade-long campaign of aggressive enforcement until he was forced out of the agency in 2015. “I mean, to get Congress to pass a bill to protect their interests in the height of an opioid epidemic just shows me how much influence they have.”
Besides the sponsors and co-sponsors of the bill, few lawmakers knew the true impact the law would have. It sailed through Congress and was passed by unanimous consent, a parliamentary procedure reserved for bills considered to be noncontroversial. The White House was equally unaware of the bill’s import when President Barack Obama signed it into law, according to interviews with former senior administration officials.
Top officials at the White House and the Justice Department have declined to discuss how the bill came to pass.
Lobbying expenses, 2014-2016
Groups reported lobbying expenditures of more than $102 million related to the Ensuring Patient Access and Effective Drug Enforcement Act and other bills.
Pharmaceutical Research and Manufacturers of America
$40.8M
CVS Health
$32.5M
National Association of Chain Drug Stores
$8M
National Community Pharmacists Association
$5.4M
AmerisourceBergen
$3.8M
Healthcare Distribution Alliance
$3.5M
McKesson
$2.9M
Rite Aid
$2.8M
Walgreens
$1.4M
Cardinal Health
$1M
Includes lobbying efforts of more than $5,000.
Source: U.S. Senate Lobbying Disclosure
Electronic Filing System
Michael Botticelli, who led the White House Office of National Drug Control Policy at the time, said neither Justice nor the DEA objected to the bill, removing a major obstacle to the president’s approval.
“We deferred to DEA, as is common practice,” he said.
The bill also was reviewed by the White House Office of Management and Budget.
“Neither the DEA nor the Justice Department informed OMB about the policy change in the bill,” a former senior OMB official with knowledge of the issue said recently. The official spoke on the condition of anonymity because of the sensitivity of internal White House deliberations.
The DEA’s top official at the time, acting administrator Chuck Rosenberg,
declined repeated requests for interviews. A senior DEA official said the agency fought the bill for years in the face of growing pressure from key members of Congress and industry lobbyists. But the DEA lost the battle and eventually was forced to accept a deal it did not want.
“They would have passed this with us or without us,” said the official, who spoke on the condition of anonymity. “Our point was that this law was completely unnecessary.”
Loretta E. Lynch, who was attorney general at the time, declined a recent interview request.
Obama also declined to discuss the law. His spokeswoman, Katie Hill, referred reporters to Botticelli’s statement.
The DEA and Justice Department have denied or delayed more than a dozen requests filed by The Post and “60 Minutes” under the Freedom of Information Act for public records that might shed additional light on the matter. Some of those requests have been pending for nearly 18 months. The Post is now suing the Justice Department in federal court for some of those records.
Hatch’s spokesman, Matt Whitlock, said the DEA, which had undergone a leadership change, did not oppose the bill in the end.
“We worked collaboratively with DEA and DOJ .?.?. and they contributed significantly to the language of the bill,” Whitlock wrote in an email. “DEA had plenty of opportunities to stop the bill and they did not do so.”
Marino declined repeated requests for comment. Marino’s staff called the U.S. Capitol Police when The Post and “60 Minutes” tried to interview the congressman at his office on Sept. 12. In the past, the congressman has said the DEA was too aggressive and needed to work more collaboratively with drug companies.
DEA officials redacted the information contained in the document above, which was obtained by The Washington Post under the Freedom of Information Act, citing an exemption from the law that protects internal agency discussions. Read the bill and other documents involved in reporting this story.
Drug industry officials and experts blame the origins of the opioid crisis on the overprescribing of pain pills by doctors. The industry notes that the DEA approves the total amount of opioids produced each year.
Industry officials defended the new law as an effort to ensure that legitimate pain patients receive their medication without disruption. The industry had long complained that federal prescription drug laws were too vague about the responsibility of companies to report suspicious orders of narcotics. The industry also complained that the DEA communicated poorly with companies — citing a 2015 report by the Government Accountability Office — and was too punitive when narcotics were diverted out of the legal drug distribution chain.
“To be clear — this law does not ‘decrease’ DEA’s enforcement against distributors,” said John Parker, a spokesman for the Healthcare Distribution Alliance, which represents drug distributors. “It supports real-time communication between all parties in order to counter the constantly evolving methods of drug diversion.”
But DEA Chief Administrative Law Judge John J. Mulrooney II
has reached the opposite conclusion.
“At a time when, by all accounts, opioid abuse, addiction and deaths were increasing markedly” the new law “imposed a dramatic diminution of the agency’s authority,” Mulrooney wrote in a draft 115-page article provided by the Marquette Law Review editorial board. He wrote that it is now “all but logically impossible” for the DEA to suspend a drug company’s operations for failing to comply with federal law. The agency declined to make Mulrooney available for an interview.
Linden Barber: a critical connection
Barber provided a critical connection between DEA leadership, Congress, and the pharmaceutical industry.
Congress
DEA/DOJ
Lobby
Industry
April 2006
Barber named top lawyer for the DEA’s Office of Diversion Control.
2006-2007
Rannazzisi and Barber launch a crackdown on drug distributors.
September 2011
After Marino introduces a third version of his bill, Congress holds a hearing. Barber testifies in favor of the legislation.
February 18, 2014
Rep. Tom Marino introduces the first version of the Ensuring Patient Access and Effective Drug Enforcement Act.
June 4, 2014
An email from a Justice legislative affairs officer says that the Marino bill was written by Barber.
January 27, 2015
After Marino introduces a third version his bill, Congress holds a hearing. Barber is the featured witness testifying in favor of the legislation.
April 19, 2016
President Obama signs the bill into law.
July 2017
Barber joins Cardinal Health as a senior vice president in charge of regulatory affairs.
Open full timeline
Deeply involved in the effort to help the industry was the DEA’s former associate chief counsel, D. Linden Barber.
While at the DEA, he helped design and carry out the early stages of the agency’s tough enforcement campaign, which targeted drug companies that were failing to report suspicious orders of narcotics.
When Barber went to work for the drug industry in 2011, he brought an intimate knowledge of the DEA’s strategy and how it could be attacked to protect the companies. He was one of dozens of DEA officials recruited by the drug industry during the past decade.
Barber played a key role in crafting an early version of the legislation that would eventually curtail the DEA’s power, according to an internal email written by a Justice Department official to a colleague. “He wrote the Marino bill,” the official wrote in 2014.
Barber declined repeated requests for an interview.
With a few words, the new law changed four decades of DEA practice. Previously, the DEA could freeze drug shipments that posed an “imminent danger” to the community, giving the agency broad authority. Now, the DEA must demonstrate that a company’s actions represent “a substantial likelihood of an immediate threat,” a much higher bar.
“There’s no way that we could meet that burden, the determination that those drugs are going to be an immediate threat, because immediate, by definition, means right now,” Rannazzisi said.
Today, Rannazzisi is a consultant for a team of lawyers suing the opioid industry. Separately, 41 state attorneys general have banded together to investigate the industry. Hundreds of counties, cities and towns also are suing.
“This is an industry that’s out of control. If they don’t follow the law in drug supply, and diversion occurs, people die. That’s just it, people die,” he said. “And what they’re saying is, ‘The heck with your compliance. We’ll just get the law changed.’ ”
Paying Kickbacks to Doctors, Yawn, next. this has been going on for a long time and everyone is guilty of that. Major drug companies like McKesson Cardinal were sued by the government for over issue of opiates and all sorts of terrible stuff including overdoses and deaths and they wanted to see someone in jail but their lawyers were willing to spend more money then the government. See two 60 minutes pieces from earlier this year. They got a 20 million dollar fine, something like that. For some reason they want to make an example out of Moran. Could it be about color? But that is Mississippi I guess. McKesson and Cardinal are still around and still making money. I just say good luck.
So they couldn't afford the 20% copay and he covered it? Pure evil.
No Hatter I have never met him./ I have been in Medical Supply and have formerly billed Medicare, Medicaid and Tricare. And let me tell you from experience it is easier to fall into problems with them then you might think. The Govt. can be like the Men in Black, coming in with dark glasses and brief cases. I stopped billing government claims about 7 years ago. There are so many rules that it promotes an impossible situation at times as doctors don't want to do what they need to do because they don't want to pay for more labor. They want their patients to think they are the greatest people on earth but when it comes to compliance with suppliers they could care less if you have the documentation you need. So in many cases suppliers will fill scripts with out the documentation having all the t's crossed etc. then comes the z-pic audit and they give you 3 weeks to come up with the documentation on every file from the previous year. The ones handling these audits are contractors who are hoping you will fail because it makes them look good to the multimillion dollar contracts that they are cashing in on and in many cases they are the most disorganized operations with tons of files stacked on desks and no body working. They don't give providers the locations or phone numbers that work of auditors. It is total chaos. That is why I think we should hear from Marco on this before forming that mob mentality.
Hatter: I appreciate the dialogue between you and Thorne. Well done, great research guys. Very helpful. I just have a question for you, I recall you stating in the past how many shares you held at the time (which I will omit here). Could you give us an idea of what percent you have offed? Or what percent you presently hold of Dewm?
I guess I am like that guy in the Titanic Film that was holding onto the rail on the back of the ship as she was going down but I am not selling sorry folks. These were free shares that I made from an early investment into amfe.
A possibility would be dispensaries in Arkansas. In a recent statement from there it said that quite a few of those who submitted applications were already in the process of building out their locations. Also that they would be able to grow 50 plants each. If Moran thought Dewm would be awarded a contract wouldn't he thinking about holding shares? And isn't that announcement about to be made prior to the end of the month? Wouldn't that be a trip to see these sellers stumbling to get back in as the price per share is soaring upward?
Dilly,Dilly